Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.55 |
| ▸ | MEN1 | O00255 | 2/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.55 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.55 |
| ▸ | MAPT | P10636 | 2/20 | 0.55 |
| ▸ | HPGD | P15428 | 2/20 | 0.55 |
| ▸ | TOP1 | P11387 | 3/20 | 0.54 |
| ▸ | CYCS | P99999 | 4/20 | 0.53 |
| ▸ | RAB9A | P51151 | 2/20 | 0.53 |
| ▸ | NPC1 | O15118 | 1/20 | 0.53 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.52 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.49 |
| ▸ | GAA | P10253 | 1/20 | 0.49 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.46 |
| ▸ | GHSR | Q92847 | 1/20 | 0.46 |
| ▸ | TERT | O14746 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16912677 | 0.88 | TOP1 (0.54) | ALDH1A1MEN1KMT2AKDM4EMAPT | |
| SCHEMBL16920374 | 0.87 | SMN1; SMN2 (0.54) | ALDH1A1KDM4EHPGDTOP1CYCS | |
| SCHEMBL8572426 | 0.87 | TOP1 (0.53) | MEN1KMT2AMAPTTOP1CYCS | |
| SCHEMBL13609844 | 0.82 | TOP1 (0.53) | ALDH1A1MEN1KMT2AKDM4EMAPT | |
| SCHEMBL16923657 | 0.82 | MEN1 (0.53) | ALDH1A1MEN1KMT2AKDM4EHPGD | |
| SCHEMBL9018604 | 0.81 | TOP1 (0.52) | ALDH1A1TOP1CYCSABCG2ENPP2 | |
| SCHEMBL2403632 | 0.81 | TOP1 (0.54) | ALDH1A1KDM4EMAPTTOP1CYCS | |
| SCHEMBL8994447 | 0.80 | TOP1 (0.60) | ALDH1A1MEN1KMT2AKDM4EMAPT | |
| Acetic Acid SCHEMBL9639956 | 0.80 | TOP1 (0.67) | TOP1CYCSABCG2ENPP2TERT | |
| SCHEMBL16920366 | 0.79 | MEN1 (0.53) | ALDH1A1MEN1KMT2AKDM4EHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9901636-B2 | Conjugate of a photosensitiser and chitosan and uses thereof | PCI BIOTECH AS (NO) | 2018-02-27 | — | — | US | disclosed |
| US-20150202293-A1 | CONJUGATE OF A PHOTOSENSITISER AND CHITOSAN AND USES THEREOF | PCI BIOTECH AS (NO) | 2015-07-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150202293-A1 | CONJUGATE OF A PHOTOSENSITISER AND CHITOSAN AND USES THEREOF | TLR3, CD47, TLR9 | ALDH1A1 3397/4885MEN1 974/4885KMT2A 3280/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.